gms | German Medical Science

68th Annual Meeting of the German Society of Neurosurgery (DGNC)
7th Joint Meeting with the British Neurosurgical Society (SBNS)

German Society of Neurosurgery (DGNC)

14 - 17 May 2017, Magdeburg

Neurosurgical management of clinically silent but GH-producing pituitary adenomas

Meeting Abstract

  • Mario Giordano - INI Hannover, Hannover, Deutschland
  • Amir Samii - INI Hannover, Leibniz Institute for neurobiology, Hannover, Deutschland
  • Hussam Metwali - INI Hannover, hannover, Deutschland
  • Rudolf Fahlbusch - International Neuroscience Institute Hannover, International Neuroscience Institute Hannover, Hannover, Deutschland

Deutsche Gesellschaft für Neurochirurgie. Society of British Neurological Surgeons. 68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 7. Joint Meeting mit der Society of British Neurological Surgeons (SBNS). Magdeburg, 14.-17.05.2017. Düsseldorf: German Medical Science GMS Publishing House; 2017. DocMO.28.01

doi: 10.3205/17dgnc169, urn:nbn:de:0183-17dgnc1693

Published: June 9, 2017

© 2017 Giordano et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objective: A subtype of functional lesions called “silent adenomas” has been identified in the 1970s. This entity consists classically in adenomas showing hormone production at the histopatological examination however without clinical signs and symptoms. We report our experience about clinically silent pituitary adenomas with invasion of the cavernous sinus describing the neurosurgical treatment strategy and follow up.

Methods: Within a series of 142 pituitary adenomas operated consecutively with the aid of intraoperative magnetic resonance imaging (MRI) (Brainsuite 1.5T), three patients were identified that were suffering from invasive but clinically silent somatotrophinomas. Tumor size, invasion pattern and hormonal features were studied preoperatively and at long-term follow-up.

Results: In two of the three cases total tumor removal was possible based on intraoperative MRI, the patients show normal hormonal status and no recurrence at three years follow-up. In the third case due to the different features of the tumor, complete resection was not possible due to invasion of the cavernous sinus and a multimodal treatment, including radiosurgery, was performed that allowed regularization of the hormonal status and control of the residual tumor.

Conclusion: Silent somatothropinomas are uncommon. Every case should be evaluated singularly taking into consideration patient´s symptoms, MRI and immunohistochemical features. Total microsurgical excision can be curative, in case of partial removal a tailored adjuvant treatment should be considered. In objectively not resectable tumors preoperative medical treatment with somatostatine analogue remains always an option.